Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Socie, Gerard [1 ]
Varoqueaux, Nathalie [2 ]
de Latour, Regis Peffault [1 ]
机构：
[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France
[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France
来源：
M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;
D O I：
10.1051/medsci/200925121126
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.
引用
收藏
页码：1126 / 1129
页数：4
相关论文
共 50 条
  • [1] Paroxysmal nocturnal hemoglobinuria and eculizumab
    Luzzatto, Lucio
    Risitano, Antonio Maria
    Notaro, Rosario
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (04): : 523 - 526
  • [2] Eculizumab in the Treatment of Paroxysmal Nocturnal Hemoglobinuria
    Hill, Anita
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 1467 - 1476
  • [3] Eculizumab (Soliris) for paroxysmal nocturnal hemoglobinuria
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1270): : 79 - 80
  • [4] Eculizumab in paroxysmal nocturnal hemoglobinuria - The author replies
    Hillmen, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2787 - 2788
  • [5] The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Young, Neal S.
    Schubert, Joerg
    Brodsky, Robert A.
    Socie, Gerard
    Muus, Petra
    Roeth, Alexander
    Szer, Jeffrey
    Elebute, Modupe O.
    Nakamura, Ryotaro
    Browne, Paul
    Risitano, Antonio M.
    Hill, Anita
    Schrezenmeier, Hubert
    Fu, Chieh-Lin
    Maciejewski, Jaroslaw
    Rollins, Scott A.
    Mojcik, Christopher F.
    Rother, Russell P.
    Luzzatto, Lucio
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12): : 1233 - 1243
  • [6] Eculizumab: A novel therapy for paroxysmal nocturnal hemoglobinuria
    Zareba, Karolina M.
    DRUGS OF TODAY, 2007, 43 (08) : 539 - 546
  • [7] Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
    Marti-Carvajal, Arturo J.
    Anand, Vidhu
    Felipe Cardona, Andres
    Sola, Ivan
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10):
  • [8] Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria
    Kelly, Richard J.
    Hoechsmann, Britta
    Szer, Jeff
    Kulasekararaj, Austin
    Path, F. R. C.
    de Guibert, Sophie
    Roeth, Alexander
    Weitz, Ilene C.
    Armstrong, Elina
    Risitano, Antonio M.
    Patriquin, Christopher J.
    Terriou, Louis
    Muus, Petra
    Hill, Anita
    Turner, Michelle P.
    Schrezenmeier, Hubert
    de latour, Regis Peffault
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (11): : 1032 - 1039
  • [9] Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
    Hillmen, Peter
    Szer, Jeff
    Weitz, Ilene
    Roeth, Alexander
    Hoechsmann, Britta
    Panse, Jens
    Usuki, Kensuke
    Griffin, Morag
    Kiladjian, Jean-Jacques
    de Castro, Carlos
    Nishimori, Hisakazu
    Tan, Lisa
    Hamdani, Mohamed
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Ajayi, Temitayo
    Risitano, Antonio
    de la Tour, Regis Peffault
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (11): : 1028 - 1037
  • [10] Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab
    Roeth, Alexander
    Duehrsen, Ulrich
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (06) : 473 - 479
12345